Work

Gtb-3650 (anti-CD16/IL-15/anti-CD33) tri-specific killer engager (TriKE®) for the treatment of high risk myelodysplastic syndromes (MDS) and refractory/relapsed (R/R) Acute Myeloid Leukemia (AML) (NCT06594445)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6947

Authors: Mark Juckett, Christopher Graham, Punita Grover, Joseph Norton, Naveen Premnath, Craig Eckfeldt, Zohar Sachs, Cassie Seichter, Andrea Hoeschen, Cameron McDonald-Hyman, Jeremy Allred, Rose Wangen, Martin Felices, Jeffrey Miller

Institution: University of Minnesota

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417020446

Cites:

Cited by: 1

Related to: